share_log

Fidelity Preferred Securities & Income ETF (BATS:FPFD) Stock Price Down 0%

富达优先证券和收益ETF(BATS: FPFD)股价下跌0%
Defense World ·  2023/01/26 15:27

Fidelity Preferred Securities & Income ETF (BATS:FPFD – Get Rating) fell 0% during mid-day trading on Wednesday . The stock traded as low as $21.30 and last traded at $21.35. 8,358 shares changed hands during mid-day trading, The stock had previously closed at $21.36.

富达优先证券和收益ETF(BATS: FPFD — 获取评级)在周三午盘交易中下跌了0%。该股的交易价格低至21.30美元,最后一次交易价格为21.35美元。8,358股在午盘交易中易手,该股此前收于21.36美元。

Fidelity Preferred Securities & Income ETF Price Performance

富达优先证券和收益ETF价格表现

The firm's 50-day moving average price is $20.31 and its 200-day moving average price is $20.36.

该公司的50天移动平均线价格为20.31美元,其200天移动平均线价格为20.36美元。

Institutional Trading of Fidelity Preferred Securities & Income ETF

富达优先证券和收益ETF的机构交易

An institutional investor recently bought a new position in Fidelity Preferred Securities & Income ETF stock. Smith Chas P & Associates PA Cpas purchased a new stake in Fidelity Preferred Securities & Income ETF (BATS:FPFD – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 10,000 shares of the company's stock, valued at approximately $198,000.

一位机构投资者最近购买了富达优先证券和收益ETF股票的新头寸。Smith Chas P & Associates PA Cpas在向美国证券交易委员会提交的最新13F表文件中显示,该公司在第四季度购买了富达优先证券与收益ETF(BATS: FPFD — Get Rating)的新股份。该基金购买了该公司10,000股股票,价值约198,000美元。

Read More

阅读更多

  • Get a free copy of the StockNews.com research report on Fidelity Preferred Securities & Income ETF (FPFD)
  • AMD Is Still One Of The Best Semiconductor Stocks Out There
  • Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
  • Is The Bottom In For Cyber-Security Stocks?
  • Union Pacific, Norfolk Southern Pull into Buying Zone
  • Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
  • 免费获取 StockNews.com 关于富达优先证券和收益ETF(FPFD)的研究报告
  • AMD 仍然是目前最好的半导体股票之一
  • 两位股息之王:强生还是雅培实验室?
  • 网络安全股票触底了吗?
  • 联合太平洋、诺福克南方航空进入买入区
  • Pliant Therapeutics 的差距上涨了 34%:还有更多上行空间?

Receive News & Ratings for Fidelity Preferred Securities & Income ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Preferred Securities & Income ETF and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收富达优先证券和收益ETF的新闻和评级 -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯,获取富达优先证券和收益ETF及相关公司的最新新闻和分析师评级的简明每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发